|
|
|
|
Direct Cost |
Indirect Cost |
|
1DP2EB020549-01 |
A Novel 3D Bioprinted Smart Vascularized Nano Tissue |
GEORGE WASHINGTON UNIVERSITY |
NIBIB |
$1,500,000 |
$787,500 |
$2,287,500 |
1F31MH103021-01A1 |
The role of TxnRd2 in cortical circuit formation |
GEORGE WASHINGTON UNIVERSITY |
NIMH |
$32,040 |
|
$32,040 |
1F32MH105293-01 |
Psychological and behavioral factors relevant to physical function in veterans |
GEORGE WASHINGTON UNIVERSITY |
NIMH |
$59,594 |
|
$59,594 |
1K01TW009484-01A1 |
A Study of Enteropathogenic Bacteria Transmitted from Animals to Humans |
GEORGE WASHINGTON UNIVERSITY |
FIC |
$123,750 |
$9,900 |
$133,650 |
1K99ES023477-01 |
The effect of endocrine disrupting chemicals on cardiac physiology |
GEORGE WASHINGTON UNIVERSITY |
NIEHS |
$97,188 |
$7,775 |
$104,963 |
1R01CA177898-01A1 |
The Role of And-1 in DNA Damage Response |
GEORGE WASHINGTON UNIVERSITY |
NCI |
$207,500 |
$121,388 |
$328,888 |
1R01CA184717-01 |
The Regulation of Cisplatin resistance in ovarian cancer |
GEORGE WASHINGTON UNIVERSITY |
NCI |
$207,500 |
$121,388 |
$328,888 |
1R01DK100916-01A1 |
Translation of social media obesity treatment into two college campus communities |
GEORGE WASHINGTON UNIVERSITY |
NIDDK |
$496,144 |
$195,118 |
$691,262 |
1R03EB019065-01 |
Ultrasound Stimulation of Pancreatic Beta Cells |
GEORGE WASHINGTON UNIVERSITY |
NIBIB |
$50,000 |
$26,250 |
$76,250 |
1R03MH102568-01 |
Pathways through Care: Decision-Making and Treatment Drop-Out in Early Psychosis |
GEORGE WASHINGTON UNIVERSITY |
NIMH |
$50,000 |
$29,250 |
$79,250 |
1R15AI105738-01A1 |
Decision Making for Social Distancing |
GEORGE WASHINGTON UNIVERSITY |
NIAID |
$298,708 |
$174,744 |
$473,452 |
1R15CA176600-01A1 |
Medicaid Tobacco Cessation: State Policies and Effectiveness |
GEORGE WASHINGTON UNIVERSITY |
NCI |
$299,799 |
$175,382 |
$475,181 |
1R21AA022205-01A1 |
ANTI INFLAMMATORY AND ANTIFIBROTIC ACTIONS OF THYMOSIN BETA 4 IN ALD |
GEORGE WASHINGTON UNIVERSITY |
NIAAA |
$118,750 |
$30,875 |
$149,625 |
1R21AI108533-01 |
HIV-1 Nef regulates activity of the ER chaperone calnexin |
GEORGE WASHINGTON UNIVERSITY |
NIAID |
$140,000 |
$81,900 |
$221,900 |
1R21AI109517-01A1 |
Developing genetic tools for a new model of infection and immunity |
GEORGE WASHINGTON UNIVERSITY |
NIAID |
$125,000 |
$71,168 |
$196,168 |
1R21AI109532-01A1 |
Antibiotic selection for schistosome transgenesis |
GEORGE WASHINGTON UNIVERSITY |
NIAID |
$150,000 |
$87,750 |
$237,750 |
1R21AI113806-01 |
Characterization of Regulated Intron Retention in T Cell Activation |
GEORGE WASHINGTON UNIVERSITY |
NIAID |
$150,000 |
$76,125 |
$226,125 |
1R21CA182662-01 |
Elucidating and targeting epigenetic oncogenic networks in pancreatic cancer |
GEORGE WASHINGTON UNIVERSITY |
NCI |
$108,750 |
$58,730 |
$167,480 |
1R21CA187857-01 |
Steroid receptor coactivator-3 and cancer stem cells |
GEORGE WASHINGTON UNIVERSITY |
NCI |
$130,500 |
$76,343 |
$206,843 |
1R21DC013122-01A1 |
Speech Perception Impairments in Healthy Normal-Hearing Adults: Neural Mechanisms |
GEORGE WASHINGTON UNIVERSITY |
NIDCD |
$200,000 |
$105,000 |
$305,000 |